QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.106.011494v1 34/12/2011    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tarning, J. Articles by Lindegårdh, N. Search for Related Content PubMed PubMed Citation Articles by Tarning, J. Articles by Lindegårdh, N.

Characterization of Human Urinary Metabolites of the Antimalarial Piperaquine

Department of Pharmacology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden (J.T., M.A.); Dalarna University College, Borlänge, Sweden (Y.B.); Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand (N.P.D., N.J.W., N.L.); Nuffield Department of Clinical Medicine, Centre for Tropical Medicine, University of Oxford, Oxford, United Kingdom (N.P.D., N.J.W., N.L.); and Department of Physical and Analytical Chemistry, Uppsala University, Uppsala, Sweden (J.B., B.A.)

Five metabolites of the antimalarial piperaquine (PQ) (1,3-bis-[4-(7-chloroquinolyl-4)-piperazinyl-1]-propane) have been identified and their molecular structures characterized. After a p.o. dose of dihydroartemisinin-piperaquine, urine collected over 16 h from two healthy subjects was analyzed using liquid chromatography (LC)/UV, LC/tandem mass spectrometry (MS/MS), Fourier transform ion cyclotron resonance (FTICR)/MS, and H NMR. Five different peaks were recognized as possible metabolites [M1, 320 m/z; M2, M3, and M4, 551 m/z (PQ + 16 m/z); and M5, 567 m/z (PQ + 32 m/z)] using LC/MS/MS with gradient elution. The proposed carboxylic M1 has a theoretical monoisotopic molecular mass of 320.1166 m/z, which is in accordance with the FTICR/MS (320.1168 m/z) findings. The LC/MS/MS results also showed a 551 m/z metabolite (M2) with a distinct difference both in polarity and fragmentation pattern compared with PQ, 7-hydroxypiperaquine, and the other 551 m/z metabolites. We suggest that this is caused by N-oxidation of PQ. The results showed two metabolites (M3 and M4) with a molecular ion at 551 m/z and similar fragmentation pattern as both PQ and 7-hydroxypiperaquine; therefore, they are likely to be hydroxylated PQ metabolites. The molecular structures of M1 and M2 were also confirmed using H NMR. Urinary excretion rate in one subject suggested a terminal elimination half-life of about 53 days for M1. Assuming formation rate-limiting kinetics, this would support recent findings that the terminal elimination half-life of PQ has been underestimated previously.

This article has been cited by other articles:

				B. R. Moore, K. F. Ilett, M. Page-Sharp, J. D. Jago, and K. T. Batty Piperaquine Pharmacodynamics and Parasite Viability in a Murine Malaria Model Antimicrob. Agents Chemother., July 1, 2009; 53(7): 2707 - 2713. [Abstract] [Full Text] [PDF]

				J. Tarning, E. A. Ashley, N. Lindegardh, K. Stepniewska, L. Phaiphun, N. P. J. Day, R. McGready, M. Ashton, F. Nosten, and N. J. White Population Pharmacokinetics of Piperaquine after Two Different Treatment Regimens with Dihydroartemisinin-Piperaquine in Patients with Plasmodium falciparum Malaria in Thailand Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1052 - 1061. [Abstract] [Full Text] [PDF]